Loading…
Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis
Approximately 70% of newly diagnosed bladder tumors are non-muscle invasive bladder cancer (NMIBC). NMIBC accounts for approximately 80% of total bladder cancer cases. Bacillus Calmette-Guérin (BCG) instillation and maintenance is considered as the standard adjuvant treatment for superficial bladder...
Saved in:
Published in: | Frontiers of medicine 2014-06, Vol.8 (2), p.241-249 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3 |
---|---|
cites | cdi_FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3 |
container_end_page | 249 |
container_issue | 2 |
container_start_page | 241 |
container_title | Frontiers of medicine |
container_volume | 8 |
creator | Pan, Jiangang Liu, Mo Zhou, Xing |
description | Approximately 70% of newly diagnosed bladder tumors are non-muscle invasive bladder cancer (NMIBC). NMIBC accounts for approximately 80% of total bladder cancer cases. Bacillus Calmette-Guérin (BCG) instillation and maintenance is considered as the standard adjuvant treatment for superficial bladder cancer. A number of randomized studies have focused on the benefit of maintenance therapy following initial BCG induction. To provide further insights into the effect of intravesical instillation on recurrence in patients with NMIBC, we analyzed this relationship by conducting an updated detailed meta-analysis. Evidence suggested that adjuvant intravesical BCG with maintenance treatment is significantly effective for the prophylaxis of tumor recurrence in patients with NMIBC. |
doi_str_mv | 10.1007/s11684-014-0328-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1530956995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>50099844</cqvip_id><sourcerecordid>1530956995</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3</originalsourceid><addsrcrecordid>eNp9UcGO0zAQjRCIXZX9AC7IiAuXgO0kTnxcVbAgrcQFztHEGbdeOU7Xjov2UzjxI_wTv8BULRXisJbsGY3fezP2K4qXgr8TnLfvkxCqq0suaFeyK_mT4lJy3ZRcyubpORftRXGV0h2nVSvRav28uJB1J7iq68vixxoCc2GJsMfkDHg2gHHe58TW4CdcFixvMkYXWMQxG6RgcowYKKXiDhaHYUnsu1u2LMyhnHIy_nC3h-T2yAYP44iRGSBK_P3rJ7sOLO9GWJBBGJnJU_akQlBqByUE8A_JpRfFMws-4dUpropvHz98XX8qb7_cfF5f35amrtulHMQIWA18UCCtNVy0FvSgpFASed3BWEmJklcWu7bTVlmrqFC3baOqUVmoVsXbo-4uzvcZ09JPLhn0HgLOOfWiqegnldYNQd_8B72bc6R5CaVr0XQtF5pQ4ogycU4pou130U0QH3rB-4N1_dG6nqzrD9bRsSpenZTzMOF4Zvw1igDyCEh0FTYY_2n9iGp3JG3dZovk3y5iSr2NcyDX4uPU16dHbOewuaeW55kazrXuaKY_ZQ7Euw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1941587019</pqid></control><display><type>article</type><title>Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis</title><source>Springer Nature</source><creator>Pan, Jiangang ; Liu, Mo ; Zhou, Xing</creator><creatorcontrib>Pan, Jiangang ; Liu, Mo ; Zhou, Xing</creatorcontrib><description>Approximately 70% of newly diagnosed bladder tumors are non-muscle invasive bladder cancer (NMIBC). NMIBC accounts for approximately 80% of total bladder cancer cases. Bacillus Calmette-Guérin (BCG) instillation and maintenance is considered as the standard adjuvant treatment for superficial bladder cancer. A number of randomized studies have focused on the benefit of maintenance therapy following initial BCG induction. To provide further insights into the effect of intravesical instillation on recurrence in patients with NMIBC, we analyzed this relationship by conducting an updated detailed meta-analysis. Evidence suggested that adjuvant intravesical BCG with maintenance treatment is significantly effective for the prophylaxis of tumor recurrence in patients with NMIBC.</description><identifier>ISSN: 2095-0217</identifier><identifier>EISSN: 2095-0225</identifier><identifier>DOI: 10.1007/s11684-014-0328-0</identifier><identifier>PMID: 24810644</identifier><language>eng</language><publisher>Heidelberg: Higher Education Press</publisher><subject>Administration, Intravesical ; bacillus Calmette-Guérin (BCG) ; BCG Vaccine - administration & dosage ; BCG Vaccine - therapeutic use ; Bladder cancer ; Health risk assessment ; Humans ; Medicine ; Medicine & Public Health ; Meta-analysis ; non-muscle invasive bladder cancer ; Randomized Controlled Trials as Topic ; Recurrence ; Research Article ; Urinary Bladder Neoplasms - drug therapy ; Urinary Bladder Neoplasms - prevention & control ; 卡介苗 ; 复发 ; 患者 ; 浸润性 ; 累积 ; 肌 ; 膀胱癌 ; 辅助治疗</subject><ispartof>Frontiers of medicine, 2014-06, Vol.8 (2), p.241-249</ispartof><rights>Copyright reserved, 2014, Higher Education Press and Springer-Verlag Berlin Heidelberg</rights><rights>Higher Education Press and Springer-Verlag Berlin Heidelberg 2014</rights><rights>Frontiers of Medicine is a copyright of Springer, 2014.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3</citedby><cites>FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/71235X/71235X.jpg</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24810644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pan, Jiangang</creatorcontrib><creatorcontrib>Liu, Mo</creatorcontrib><creatorcontrib>Zhou, Xing</creatorcontrib><title>Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis</title><title>Frontiers of medicine</title><addtitle>Front. Med</addtitle><addtitle>Frontiers of Medicine</addtitle><description>Approximately 70% of newly diagnosed bladder tumors are non-muscle invasive bladder cancer (NMIBC). NMIBC accounts for approximately 80% of total bladder cancer cases. Bacillus Calmette-Guérin (BCG) instillation and maintenance is considered as the standard adjuvant treatment for superficial bladder cancer. A number of randomized studies have focused on the benefit of maintenance therapy following initial BCG induction. To provide further insights into the effect of intravesical instillation on recurrence in patients with NMIBC, we analyzed this relationship by conducting an updated detailed meta-analysis. Evidence suggested that adjuvant intravesical BCG with maintenance treatment is significantly effective for the prophylaxis of tumor recurrence in patients with NMIBC.</description><subject>Administration, Intravesical</subject><subject>bacillus Calmette-Guérin (BCG)</subject><subject>BCG Vaccine - administration & dosage</subject><subject>BCG Vaccine - therapeutic use</subject><subject>Bladder cancer</subject><subject>Health risk assessment</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Meta-analysis</subject><subject>non-muscle invasive bladder cancer</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Recurrence</subject><subject>Research Article</subject><subject>Urinary Bladder Neoplasms - drug therapy</subject><subject>Urinary Bladder Neoplasms - prevention & control</subject><subject>卡介苗</subject><subject>复发</subject><subject>患者</subject><subject>浸润性</subject><subject>累积</subject><subject>肌</subject><subject>膀胱癌</subject><subject>辅助治疗</subject><issn>2095-0217</issn><issn>2095-0225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9UcGO0zAQjRCIXZX9AC7IiAuXgO0kTnxcVbAgrcQFztHEGbdeOU7Xjov2UzjxI_wTv8BULRXisJbsGY3fezP2K4qXgr8TnLfvkxCqq0suaFeyK_mT4lJy3ZRcyubpORftRXGV0h2nVSvRav28uJB1J7iq68vixxoCc2GJsMfkDHg2gHHe58TW4CdcFixvMkYXWMQxG6RgcowYKKXiDhaHYUnsu1u2LMyhnHIy_nC3h-T2yAYP44iRGSBK_P3rJ7sOLO9GWJBBGJnJU_akQlBqByUE8A_JpRfFMws-4dUpropvHz98XX8qb7_cfF5f35amrtulHMQIWA18UCCtNVy0FvSgpFASed3BWEmJklcWu7bTVlmrqFC3baOqUVmoVsXbo-4uzvcZ09JPLhn0HgLOOfWiqegnldYNQd_8B72bc6R5CaVr0XQtF5pQ4ogycU4pou130U0QH3rB-4N1_dG6nqzrD9bRsSpenZTzMOF4Zvw1igDyCEh0FTYY_2n9iGp3JG3dZovk3y5iSr2NcyDX4uPU16dHbOewuaeW55kazrXuaKY_ZQ7Euw</recordid><startdate>20140601</startdate><enddate>20140601</enddate><creator>Pan, Jiangang</creator><creator>Liu, Mo</creator><creator>Zhou, Xing</creator><general>Higher Education Press</general><general>Springer Nature B.V</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20140601</creationdate><title>Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis</title><author>Pan, Jiangang ; Liu, Mo ; Zhou, Xing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Administration, Intravesical</topic><topic>bacillus Calmette-Guérin (BCG)</topic><topic>BCG Vaccine - administration & dosage</topic><topic>BCG Vaccine - therapeutic use</topic><topic>Bladder cancer</topic><topic>Health risk assessment</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Meta-analysis</topic><topic>non-muscle invasive bladder cancer</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Recurrence</topic><topic>Research Article</topic><topic>Urinary Bladder Neoplasms - drug therapy</topic><topic>Urinary Bladder Neoplasms - prevention & control</topic><topic>卡介苗</topic><topic>复发</topic><topic>患者</topic><topic>浸润性</topic><topic>累积</topic><topic>肌</topic><topic>膀胱癌</topic><topic>辅助治疗</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pan, Jiangang</creatorcontrib><creatorcontrib>Liu, Mo</creatorcontrib><creatorcontrib>Zhou, Xing</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Frontiers of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Jiangang</au><au>Liu, Mo</au><au>Zhou, Xing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis</atitle><jtitle>Frontiers of medicine</jtitle><stitle>Front. Med</stitle><addtitle>Frontiers of Medicine</addtitle><date>2014-06-01</date><risdate>2014</risdate><volume>8</volume><issue>2</issue><spage>241</spage><epage>249</epage><pages>241-249</pages><issn>2095-0217</issn><eissn>2095-0225</eissn><abstract>Approximately 70% of newly diagnosed bladder tumors are non-muscle invasive bladder cancer (NMIBC). NMIBC accounts for approximately 80% of total bladder cancer cases. Bacillus Calmette-Guérin (BCG) instillation and maintenance is considered as the standard adjuvant treatment for superficial bladder cancer. A number of randomized studies have focused on the benefit of maintenance therapy following initial BCG induction. To provide further insights into the effect of intravesical instillation on recurrence in patients with NMIBC, we analyzed this relationship by conducting an updated detailed meta-analysis. Evidence suggested that adjuvant intravesical BCG with maintenance treatment is significantly effective for the prophylaxis of tumor recurrence in patients with NMIBC.</abstract><cop>Heidelberg</cop><pub>Higher Education Press</pub><pmid>24810644</pmid><doi>10.1007/s11684-014-0328-0</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2095-0217 |
ispartof | Frontiers of medicine, 2014-06, Vol.8 (2), p.241-249 |
issn | 2095-0217 2095-0225 |
language | eng |
recordid | cdi_proquest_miscellaneous_1530956995 |
source | Springer Nature |
subjects | Administration, Intravesical bacillus Calmette-Guérin (BCG) BCG Vaccine - administration & dosage BCG Vaccine - therapeutic use Bladder cancer Health risk assessment Humans Medicine Medicine & Public Health Meta-analysis non-muscle invasive bladder cancer Randomized Controlled Trials as Topic Recurrence Research Article Urinary Bladder Neoplasms - drug therapy Urinary Bladder Neoplasms - prevention & control 卡介苗 复发 患者 浸润性 累积 肌 膀胱癌 辅助治疗 |
title | Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A47%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20intravesical%20bacillus%20Calmette-Guerin%20reduce%20recurrence%20in%20patients%20with%20non-muscle%20invasive%20bladder%20cancer%EF%BC%9F%20An%20update%20and%20cumulative%20meta-analysis&rft.jtitle=Frontiers%20of%20medicine&rft.au=Pan,%20Jiangang&rft.date=2014-06-01&rft.volume=8&rft.issue=2&rft.spage=241&rft.epage=249&rft.pages=241-249&rft.issn=2095-0217&rft.eissn=2095-0225&rft_id=info:doi/10.1007/s11684-014-0328-0&rft_dat=%3Cproquest_cross%3E1530956995%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1941587019&rft_id=info:pmid/24810644&rft_cqvip_id=50099844&rfr_iscdi=true |